Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review
- PMID: 16565093
- PMCID: PMC1420708
- DOI: 10.1136/bmj.38755.366331.2F
Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review
Abstract
Objective: To review systematically the evidence for an effect of long chain and shorter chain omega 3 fatty acids on total mortality, cardiovascular events, and cancer.
Data sources: Electronic databases searched to February 2002; authors contacted and bibliographies of randomised controlled trials (RCTs) checked to locate studies.
Review methods: Review of RCTs of omega 3 intake for (3) 6 months in adults (with or without risk factors for cardiovascular disease) with data on a relevant outcome. Cohort studies that estimated omega 3 intake and related this to clinical outcome during at least 6 months were also included. Application of inclusion criteria, data extraction, and quality assessments were performed independently in duplicate.
Results: Of 15,159 titles and abstracts assessed, 48 RCTs (36,913 participants) and 41 cohort studies were analysed. The trial results were inconsistent. The pooled estimate showed no strong evidence of reduced risk of total mortality (relative risk 0.87, 95% confidence interval 0.73 to 1.03) or combined cardiovascular events (0.95, 0.82 to 1.12) in participants taking additional omega 3 fats. The few studies at low risk of bias were more consistent, but they showed no effect of omega 3 on total mortality (0.98, 0.70 to 1.36) or cardiovascular events (1.09, 0.87 to 1.37). When data from the subgroup of studies of long chain omega 3 fats were analysed separately, total mortality (0.86, 0.70 to 1.04; 138 events) and cardiovascular events (0.93, 0.79 to 1.11) were not clearly reduced. Neither RCTs nor cohort studies suggested increased risk of cancer with a higher intake of omega 3 (trials: 1.07, 0.88 to 1.30; cohort studies: 1.02, 0.87 to 1.19), but clinically important harm could not be excluded.
Conclusion: Long chain and shorter chain omega 3 fats do not have a clear effect on total mortality, combined cardiovascular events, or cancer.
Figures
![Fig 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/1420708/bin/hool301135.f1.gif)
![Fig 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/1420708/bin/hool301135.f2.gif)
![Fig 3](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/1420708/bin/hool301135.f3.gif)
![Fig 4](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/1420708/bin/hool301135.f4.gif)
![Fig 5](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/1420708/bin/hool301135.f5.gif)
Comment in
-
Oily fish and omega 3 fat supplements.BMJ. 2006 Apr 1;332(7544):739-40. doi: 10.1136/bmj.38798.680185.47. Epub 2006 Mar 24. BMJ. 2006. PMID: 16565094 Free PMC article. No abstract available.
-
Risks and benefits of omega 3 fats: a few thoughts on systematic review.BMJ. 2006 Apr 15;332(7546):915; discussion 915-6. doi: 10.1136/bmj.332.7546.915-a. BMJ. 2006. PMID: 16613979 Free PMC article. No abstract available.
-
Risks and benefits of omega 3 fats: health benefits of omega 3 fats are in doubt.BMJ. 2006 Apr 15;332(7546):915; discussion 915-6. doi: 10.1136/bmj.332.7546.915. BMJ. 2006. PMID: 16613980 Free PMC article. No abstract available.
Similar articles
-
Omega 3 fatty acids for prevention and treatment of cardiovascular disease.Cochrane Database Syst Rev. 2004 Oct 18;(4):CD003177. doi: 10.1002/14651858.CD003177.pub2. Cochrane Database Syst Rev. 2004. Update in: Cochrane Database Syst Rev. 2018 Jul 18;7:CD003177. doi: 10.1002/14651858.CD003177.pub3. PMID: 15495044 Free PMC article. Updated. Review.
-
Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease.Cochrane Database Syst Rev. 2020 Feb 29;3(3):CD003177. doi: 10.1002/14651858.CD003177.pub5. Cochrane Database Syst Rev. 2020. PMID: 32114706 Free PMC article.
-
Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease.Cochrane Database Syst Rev. 2018 Nov 30;11(11):CD003177. doi: 10.1002/14651858.CD003177.pub4. Cochrane Database Syst Rev. 2018. Update in: Cochrane Database Syst Rev. 2020 Feb 29;3:CD003177. doi: 10.1002/14651858.CD003177.pub5. PMID: 30521670 Free PMC article. Updated.
-
Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease.Cochrane Database Syst Rev. 2018 Jul 18;7(7):CD003177. doi: 10.1002/14651858.CD003177.pub3. Cochrane Database Syst Rev. 2018. Update in: Cochrane Database Syst Rev. 2018 Nov 30;11:CD003177. doi: 10.1002/14651858.CD003177.pub4. PMID: 30019766 Free PMC article. Updated. Review.
-
Omega-6 fats for the primary and secondary prevention of cardiovascular disease.Cochrane Database Syst Rev. 2018 Nov 29;11(11):CD011094. doi: 10.1002/14651858.CD011094.pub4. Cochrane Database Syst Rev. 2018. PMID: 30488422 Free PMC article.
Cited by
-
Carnitine O-octanoyltransferase (CROT) deficiency in mice leads to an increase of omega-3 fatty acids.Front Mol Biosci. 2024 Jul 15;11:1374316. doi: 10.3389/fmolb.2024.1374316. eCollection 2024. Front Mol Biosci. 2024. PMID: 39076376 Free PMC article.
-
Chemical Composition and Lipid Bioactive Components of Centaurea thracica Dwelling in Bulgaria.Molecules. 2024 Jul 11;29(14):3282. doi: 10.3390/molecules29143282. Molecules. 2024. PMID: 39064861 Free PMC article.
-
Development of sustainable downstream processing for nutritional oil production.Front Bioeng Biotechnol. 2023 Oct 10;11:1227889. doi: 10.3389/fbioe.2023.1227889. eCollection 2023. Front Bioeng Biotechnol. 2023. PMID: 37885455 Free PMC article. Review.
-
Effects of Omega-3 Polyunsaturated Fatty Acids Intake on Vasomotor Symptoms, Sleep Quality and Depression in Postmenopausal Women: A Systematic Review.Nutrients. 2023 Sep 30;15(19):4231. doi: 10.3390/nu15194231. Nutrients. 2023. PMID: 37836515 Free PMC article. Review.
-
A randomized clinical trial of omega-3 fatty acid and vitamin D supplementation on electrocardiographic risk profiles.Sci Rep. 2023 Jul 15;13(1):11454. doi: 10.1038/s41598-023-38344-x. Sci Rep. 2023. PMID: 37454148 Free PMC article. Clinical Trial.
References
-
- Bang HO, Dyerberg J. Plasma lipids and lipoproteins in Greenlandic west coast Eskimos. Acta Med Scand 1972;192: 85-94. - PubMed
-
- Nettleton JA. Omega-3 fatty acids: comparison of plant and seafood sources in human nutrition. J Am Diet Assoc 1991;91: 331-7. - PubMed
-
- Bhatnagar D, Durrington PN. Omega-3 fatty acids: their role in the prevention and treatment of atherosclerosis related risk factors and complications. Int J Clin Pract 2003;57: 305-14. - PubMed
-
- Thies F, Garry JM, Yaqoob P, Rerkasm K, Williams J, Shearman CP, et al. Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial. Lancet 2003;361: 477-85. - PubMed
-
- Geelen A, Brouwer IA, Zock PL, Katan MB. Antiarrhythmic effects of n-3 fatty acids: evidence from human studies. Curr Opin Lipidol 2004;15: 25-30. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources